Literature DB >> 16518401

The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells.

Yuin-Han Loh1, Qiang Wu, Joon-Lin Chew, Vinsensius B Vega, Weiwei Zhang, Xi Chen, Guillaume Bourque, Joshy George, Bernard Leong, Jun Liu, Kee-Yew Wong, Ken W Sung, Charlie W H Lee, Xiao-Dong Zhao, Kuo-Ping Chiu, Leonard Lipovich, Vladimir A Kuznetsov, Paul Robson, Lawrence W Stanton, Chia-Lin Wei, Yijun Ruan, Bing Lim, Huck-Hui Ng.   

Abstract

Oct4 and Nanog are transcription factors required to maintain the pluripotency and self-renewal of embryonic stem (ES) cells. Using the chromatin immunoprecipitation paired-end ditags method, we mapped the binding sites of these factors in the mouse ES cell genome. We identified 1,083 and 3,006 high-confidence binding sites for Oct4 and Nanog, respectively. Comparative location analyses indicated that Oct4 and Nanog overlap substantially in their targets, and they are bound to genes in different configurations. Using de novo motif discovery algorithms, we defined the cis-acting elements mediating their respective binding to genomic sites. By integrating RNA interference-mediated depletion of Oct4 and Nanog with microarray expression profiling, we demonstrated that these factors can activate or suppress transcription. We further showed that common core downstream targets are important to keep ES cells from differentiating. The emerging picture is one in which Oct4 and Nanog control a cascade of pathways that are intricately connected to govern pluripotency, self-renewal, genome surveillance and cell fate determination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16518401     DOI: 10.1038/ng1760

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  1016 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  Distinct epigenomic landscapes of pluripotent and lineage-committed human cells.

Authors:  R David Hawkins; Gary C Hon; Leonard K Lee; Queminh Ngo; Ryan Lister; Mattia Pelizzola; Lee E Edsall; Samantha Kuan; Ying Luu; Sarit Klugman; Jessica Antosiewicz-Bourget; Zhen Ye; Celso Espinoza; Saurabh Agarwahl; Li Shen; Victor Ruotti; Wei Wang; Ron Stewart; James A Thomson; Joseph R Ecker; Bing Ren
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

Review 3.  The biology of head and neck cancer stem cells.

Authors:  Zhaocheng Zhang; Manoel Sant'Ana Filho; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

4.  Expression pattern of embryonic stem cell markers in DFAT cells and ADSCs.

Authors:  Qian Gao; Lili Zhao; Ziyi Song; Gongshe Yang
Journal:  Mol Biol Rep       Date:  2012-01-12       Impact factor: 2.316

Review 5.  Epigenetic landscape of pluripotent stem cells.

Authors:  Ji Woong Han; Young-sup Yoon
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

Review 6.  Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Authors:  Robert Strauss; Petra Hamerlik; André Lieber; Jiri Bartek
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

Review 7.  Genomic location analysis by ChIP-Seq.

Authors:  Artem Barski; Keji Zhao
Journal:  J Cell Biochem       Date:  2009-05-01       Impact factor: 4.429

Review 8.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

9.  Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer.

Authors:  Yin-Ju Chen; Chia-Chun Kuo; Lai-Lei Ting; Long-Sheng Lu; Ya-Ching Lu; Ann-Joy Cheng; Yun-Tien Lin; Chien-Ho Chen; Jo-Ting Tsai; Jeng-Fong Chiou
Journal:  Oncol Lett       Date:  2017-11-24       Impact factor: 2.967

10.  Reversible Disruption of Specific Transcription Factor-DNA Interactions Using CRISPR/Cas9.

Authors:  S Ali Shariati; Antonia Dominguez; Shicong Xie; Marius Wernig; Lei S Qi; Jan M Skotheim
Journal:  Mol Cell       Date:  2019-05-02       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.